A detailed history of Global Wealth Strategies & Associates transactions in Eli Lilly & CO stock. As of the latest transaction made, Global Wealth Strategies & Associates holds 627 shares of LLY stock, worth $572,294. This represents 0.2% of its overall portfolio holdings.

Number of Shares
627
Previous 613 2.28%
Holding current value
$572,294
Previous $477 Million 19.04%
% of portfolio
0.2%
Previous 0.18%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

BUY
$724.87 - $909.04 $10,148 - $12,726
14 Added 2.28%
627 $568 Million
Q1 2024

Apr 01, 2024

SELL
$592.2 - $792.28 $8,883 - $11,884
-15 Reduced 2.39%
613 $477 Million
Q4 2023

Jan 02, 2024

SELL
$525.19 - $619.13 $7,877 - $9,286
-15 Reduced 2.33%
628 $366 Million
Q3 2023

Oct 20, 2023

SELL
$434.7 - $599.3 $8,694 - $11,986
-20 Reduced 3.02%
643 $345 Million
Q4 2022

Jan 17, 2023

BUY
$321.55 - $374.67 $213,187 - $248,406
663 New
663 $243 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $867B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Global Wealth Strategies & Associates Portfolio

Follow Global Wealth Strategies & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Wealth Strategies & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Global Wealth Strategies & Associates with notifications on news.